Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
H D Perez, … , D E Chenoweth, I M Goldstein
H D Perez, … , D E Chenoweth, I M Goldstein
Published December 1, 1986
Citation Information: J Clin Invest. 1986;78(6):1589-1595. https://doi.org/10.1172/JCI112751.
View: Text | PDF
Research Article

Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.

  • Text
  • PDF
Abstract

The chemotactic activity of human C5a des Arg is enhanced significantly by an anionic polypeptide (cochemotaxin) in normal human serum and plasma. We have found that the cochemotaxin attaches to the oligosaccharide chain of native C5a des Arg to form a complex with potent chemotactic activity for human polymorphonuclear leukocytes. Although capable of enhancing the chemotactic activity of native C5a des Arg, the cochemotaxin had no effect on the chemotactic activity of either deglycosylated C5a des Arg, native C5a, or N-formyl-methionyl-leucyl-phenylalanine. Of the known components of the oligosaccharide chain, only sialic acid prevented enhancement by the cochemotaxin of the chemotactic activity exhibited by native C5a des Arg. Sialic acid also prevented the formation of C5a des Arg-cochemotaxin complexes, detected by acid polyacrylamide gel electrophoresis, molecular sieve chromatography on polyacrylamide gels, and sucrose density gradient ultracentrifugation.

Authors

H D Perez, D E Chenoweth, I M Goldstein

×

Total citations by year

Year: 1997 1994 1991 1990 1989 1988 Total
Citations: 1 1 1 2 3 4 12
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (12)

Title and authors Publication Year
C5aR ligand peptide 3D QSAR study performed with an applied linear conformation
C Anderson, GE Kellogg, RJ Freer
The Journal of Peptide Research 1997
Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: An explanation for its cochemotaxin activity
HD Perez
Inflammation 1994
Infectious diseases associated with complement deficiencies
JE Figueroa, P Densen
Clinical microbiology reviews 1991
A factor in serum lowers resistance and opens tight junctions of MDCK cells
G Conyers, L Milks, M Conklyn, H Showell, E Cramer
American journal of physiology. Cell physiology 1990
A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc)
R Hoffmann, A Braun, H Cleve
Human Genetics 1990
Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall
AR Huber, SJ Weiss
Journal of Clinical Investigation 1989
Pharmacology of the Skin I
MW Greaves, S Shuster
1989
Membrane-bound Protein Kinase C Modulates Receptor Affinity and Chemotaetic Responsiveness of Lewis Lung Carcinoma Sublines to an Elastin-derived Peptide
CH Blood, BR Zetter
The Journal of biological chemistry 1989
Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin)
HD Perez, E Kelly, D Chenoweth, F Elfman
Journal of Clinical Investigation 1988
Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg
RR Kew, RO Webster
Journal of Clinical Investigation 1988
Biological properties of human C5a: selected in vitro and in vivo studies
KB Yancey
Clinical & Experimental Immunology 1988
The Chemotactic Peptide Receptor: A Model for Future Understanding of Chemotactic Disorders
RA Allen, AE Traynor, AG Omann, AJ Jesaitis
Hematology/Oncology Clinics of North America 1988

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts